Key result
Gynaecological cancer surgery carries a high risk of venous thromboembolism, occurring in 6-7% of patients despite standard prophylaxis, highlighting the need for individualized extended prophylaxis.
Why the study?
Gynaecological cancer surgery has evolved with minimally invasive surgery and shorter hospital stays, prompting an evaluation of VTE risk and the role of extended thromboprophylaxis in this era.
Does extended thromboprophylaxis reduce venous thromboembolism in patients undergoing minimally invasive surgery for gynaecological cancers?
Design
Review
Authors
Loading...
Persistent VTE risk after gynaecological cancer surgery supports extended prophylaxis consideration; leaves optimal regimen and duration open for trials.
Does extended thromboprophylaxis reduce venous thromboembolism in patients undergoing minimally invasive surgery for gynaecological cancers?
Extended thromboprophylaxis may not be justified for all patients undergoing minimally invasive surgery for gynaecological cancers due to low VTE risk, highlighting the need for individualized risk assessment.
Ibrahim et al. (2021) conducted a review in Gynaecological cancers. Extended thromboprophylaxis was evaluated on Venous thromboembolism. Gynaecological cancer surgery carries a high risk of venous thromboembolism, occurring in 6-7% of patients despite standard prophylaxis, highlighting the need for individualized extended prophylaxis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: